<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">Colorectal cancer</z:e> is one of the leading causes of <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> related <z:hpo ids='HP_0011420'>deaths</z:hpo> in Western countries and is becoming increasingly common in Asia </plain></SENT>
<SENT sid="1" pm="."><plain><z:chebi fb="0" ids="17226">Rosmarinic acid</z:chebi> (RA), one of the major components of <z:chebi fb="0" ids="26195">polyphenol</z:chebi> possesses attractive remedial features </plain></SENT>
<SENT sid="2" pm="."><plain>The purpose of this study is to investigate the possible chemopreventive mechanism of action of RA against 1,2-dimethylhydrazine (DMH) induced rat colon <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> by evaluating the circulatory <z:chebi fb="11" ids="22586">antioxidant</z:chebi> status and colonic <z:mp ids='MP_0001794'>bacterial</z:mp> enzymes activities </plain></SENT>
<SENT sid="3" pm="."><plain>Additionally, we analyzed the <z:mpath ids='MPATH_557'>aberrant crypt foci</z:mpath> (ACF) formation and multiplicity in the colon of experimental groups </plain></SENT>
<SENT sid="4" pm="."><plain>Wistar male rats were divided into six groups </plain></SENT>
<SENT sid="5" pm="."><plain>Group 1 was control rats, group 2 rats received RA (10 mg/kg b.w., p.o </plain></SENT>
<SENT sid="6" pm="."><plain>everyday), rats in groups 3-6 received DMH (20 mg/kg b.w., s.c.) for the first 4 weeks </plain></SENT>
<SENT sid="7" pm="."><plain>In addition to DMH, groups 4-6 received 2.5, 5, and 10 mg/kg b.w </plain></SENT>
<SENT sid="8" pm="."><plain>RA respectively </plain></SENT>
<SENT sid="9" pm="."><plain>The results revealed that supplementation with RA significantly reduced the formation of ACF and ACF multiplicity in DMH treated rats </plain></SENT>
<SENT sid="10" pm="."><plain>Moreover RA supplementation prevented the alterations in circulatory <z:chebi fb="11" ids="22586">antioxidant</z:chebi> enzymes and colonic <z:mp ids='MP_0001794'>bacterial</z:mp> enzymes activities </plain></SENT>
<SENT sid="11" pm="."><plain>Overall, our results showed that <z:hpo ids='HP_0000001'>all</z:hpo> three doses of RA inhibited <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e>, though the effect of the intermediary dose of 5 mg/kg b.w. was more pronounced </plain></SENT>
</text></document>